omega-n-methylarginine has been researched along with hirudin in 2 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (hirudin) | Trials (hirudin) | Recent Studies (post-2010) (hirudin) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 3,658 | 378 | 995 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pearson, JD; Royston, BD; Royston, D | 1 |
Baker, JE; Fu, X; Gross, GJ; Hsu, A; Strande, JL; Su, J | 1 |
2 other study(ies) available for omega-n-methylarginine and hirudin
Article | Year |
---|---|
Aprotinin inhibits platelet adhesion to endothelial cells.
Topics: Aprotinin; Arginine; Aspirin; Cells, Cultured; Collagen; Depression, Chemical; Endothelium, Vascular; Hirudins; Humans; Infant, Newborn; Nitric Oxide; omega-N-Methylarginine; Plastics; Platelet Adhesiveness; Thrombin; Umbilical Veins | 1992 |
SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Topics: Androstadienes; Animals; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glyburide; Hirudins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Oligopeptides; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium Channel Blockers; Potassium Channels; Proto-Oncogene Proteins c-akt; Pyrroles; Quinazolines; Rats; Rats, Sprague-Dawley; Receptor, PAR-1; Recombinant Proteins; Research Design; RNA, Messenger; Signal Transduction; Thrombin; Time Factors; Ventricular Function, Left; Wortmannin | 2007 |